140 related articles for article (PubMed ID: 34387136)
1. Amoxicillin chewable tablets intended for pediatric use: formulation development, stability evaluation and taste assessment.
Synaridou MS; Monou PK; Zacharis CK; Fatouros DG; Panderi I; Markopoulou CK
Pharm Dev Technol; 2021 Nov; 26(9):978-988. PubMed ID: 34387136
[TBL] [Abstract][Full Text] [Related]
2. Solid Dosage Forms of Dexamethasone Sodium Phosphate Intended for Pediatric Use: Formulation and Stability Studies.
Synaridou MS; Andriotis EG; Zacharis CK; Fatouros DG; Markopoulou CK
Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32295189
[TBL] [Abstract][Full Text] [Related]
3. Formulation and biopharmaceutical evaluation of bitter taste masking microparticles containing azithromycin loaded in dispersible tablets.
Tung NT; Tran CS; Nguyen TL; Hoang T; Trinh TD; Nguyen TN
Eur J Pharm Biopharm; 2018 May; 126():187-200. PubMed ID: 28359878
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique.
Shah PP; Mashru RC
AAPS PharmSciTech; 2008; 9(2):494-500. PubMed ID: 18431657
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary peptide delivery: effect of taste-masking excipients on leuprolide suspension metered-dose inhalers.
Zheng JY; Fulu MY; Lee DY; Barber TE; Adjei AL
Pharm Dev Technol; 2001 Nov; 6(4):521-30. PubMed ID: 11775953
[TBL] [Abstract][Full Text] [Related]
6. Formulation studies for mirtazapine orally disintegrating tablets.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
[TBL] [Abstract][Full Text] [Related]
7. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
Chandrasekaran P; Kandasamy R
AAPS PharmSciTech; 2017 Aug; 18(6):1972-1986. PubMed ID: 27921260
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of taste-masked levocetirizine dihydrochloride orally disintegrating tablets.
Devireddy SR; Gonugunta CS; Veerareddy PR
PDA J Pharm Sci Technol; 2009; 63(6):521-6. PubMed ID: 20169858
[TBL] [Abstract][Full Text] [Related]
10. Multiple-layer compression-coated tablets: formulation and humidity studies of novel chewable amoxicillin/clavulanate tablet formulations.
Wardrop J; Jaber AB; Ayres JW
Drug Dev Ind Pharm; 1998 Aug; 24(8):729-36. PubMed ID: 9876520
[TBL] [Abstract][Full Text] [Related]
11. Effects of liquisolid formulations on dissolution of naproxen.
Tiong N; Elkordy AA
Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
[TBL] [Abstract][Full Text] [Related]
12. Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications.
Freerks L; Sommerfeldt J; Löper PC; Klein S
Eur J Pharm Biopharm; 2020 Nov; 156():11-19. PubMed ID: 32871197
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
Drašković M; Medarević D; Aleksić I; Parojčić J
Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420
[TBL] [Abstract][Full Text] [Related]
14. Orally disintegrating tablet of novel salt of antiepileptic drug: formulation strategy and evaluation.
Rahman Z; Siddiqui A; Khan MA
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1300-9. PubMed ID: 23800704
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin.
Ge Z; Yang M; Wang Y; Shan L; Gao C
Drug Dev Ind Pharm; 2015 Jun; 41(6):934-41. PubMed ID: 24785576
[TBL] [Abstract][Full Text] [Related]
16. Gabapentin-saccharin co-crystals with enhanced physicochemical properties and
Soliman II; Kandil SM; Abdou EM
Pharm Dev Technol; 2020 Feb; 25(2):227-236. PubMed ID: 31671004
[TBL] [Abstract][Full Text] [Related]
17. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
[TBL] [Abstract][Full Text] [Related]
18. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate.
Sheshala R; Khan N; Darwis Y
Chem Pharm Bull (Tokyo); 2011; 59(8):920-8. PubMed ID: 21804234
[TBL] [Abstract][Full Text] [Related]
19. Novel levocetirizine HCl tablets with enhanced palatability: synergistic effect of combining taste modifiers and effervescence technique.
Labib GS
Drug Des Devel Ther; 2015; 9():5135-46. PubMed ID: 26379426
[TBL] [Abstract][Full Text] [Related]
20. Sustained release of amoxicillin from ethyl cellulose-coated amoxicillin/chitosan-cyclodextrin-based tablets.
Songsurang K; Pakdeebumrung J; Praphairaksit N; Muangsin N
AAPS PharmSciTech; 2011 Mar; 12(1):35-45. PubMed ID: 21161458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
